Skip to main content

Table 1 Baseline characteristics

From: Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer

Characteristics

N

Median (Range)

Total patients

110

 

Age

110

74.5 (53–94)

Patients without prior docetaxel exposure

67

 

Patients with prior docetaxel exposure

43

 

Prostate-specific antigen μg/ml

110

42.3 (2.5–3810)

Alkaline Phosphate U/l

87

101 (9.1–1600)

Albumin g/l

73

3.8 (2.5–4.8)

Hemoglobin g/l

72

12.4 (8.4–15)

Neutrophil to Lymphocyte Ratio

105

3.6 (0.7–18)